SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-145703
Filing Date
2021-04-30
Accepted
2021-04-30 17:21:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d240505ddefa14a.htm DEFA14A 14901
2 GRAPHIC g240505dsp048.jpg GRAPHIC 191023
  Complete submission text file 0001193125-21-145703.txt   279123
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39676 | Film No.: 21879931
SIC: 2836 Biological Products, (No Diagnostic Substances)